213 related articles for article (PubMed ID: 11454669)
21. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
22. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
23. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
[TBL] [Abstract][Full Text] [Related]
25. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
[TBL] [Abstract][Full Text] [Related]
26. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.
Ricciardelli C; Choong CS; Buchanan G; Vivekanandan S; Neufing P; Stahl J; Marshall VR; Horsfall DJ; Tilley WD
Prostate; 2005 Apr; 63(1):19-28. PubMed ID: 15378523
[TBL] [Abstract][Full Text] [Related]
28. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
29. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
[TBL] [Abstract][Full Text] [Related]
31. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
32. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
34. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
35. [Androgen and estrogen receptors in intact, hyperplastic, peritumorous and malignant prostate tissues: a link to proliferation and apoptosis (immunochemical study)].
Fedosenko KV; Koval'skiĭ GB
Vopr Onkol; 2005; 51(2):216-8. PubMed ID: 16223004
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
37. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy.
Kruithof-Dekker IG; Têtu B; Janssen PJ; Van der Kwast TH
J Urol; 1996 Sep; 156(3):1194-7. PubMed ID: 8709345
[TBL] [Abstract][Full Text] [Related]
38. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.
Meng MV; Grossfeld GD; Williams GH; Dilworth S; Stoeber K; Mulley TW; Weinberg V; Carroll PR; Tlsty TD
Clin Cancer Res; 2001 Sep; 7(9):2712-8. PubMed ID: 11555583
[TBL] [Abstract][Full Text] [Related]
39. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
[TBL] [Abstract][Full Text] [Related]
40. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]